Vitalea Science: AMS Services for Drug Development


company	services	news	documents	contact
	A c c e l e r a t o r M a s s S p e c t r o m e t r y Research Services for Drug Development
New Press Release ... Data from a human micro-dose trial, produced by Vitalea Science, Inc. using Accelerator Mass Spectrometry (AMS) technology, demonstrated that RDEA436, a MEK inhibitors has a long half-life and favorable PK parameters ... New Publications Use of Accelerator Mass Spectrometry to measure the Pharmacokinetics and... Methods and applications of HPLC-AMS ... Disposition of 14C-b-carotene following delivery with autologous triacylglyceride-rich lipoproteins ... ©2007 Vitalea Science, Inc.	Welcome to Vitalea Science Vitalea brings the world’s experts in Accelerator Mass Spectrometry Technology (AMS) to work closely with clients to safely measure pharmacokinetics in humans and more effectively accelerate drug development, while reducing overall costs. Harnessing the power of the AMS atom counter, Vitalea provides ADME, bioavailability, and pharmacokinetic evaluations at the very earliest stages of clinical drug development: Phase 0 microdosing and Phase I microtracing. “Streamlining early clinical development with microdosing and microtracers” enables better development decisions, increasing potential success while reducing costs of failure for new drugs, formulations and delivery strategies. We are partnered with several clinics in many countries to offer innovative clinical options to your drug development program. Please visit Our Partners for more information. We welcome the opportunity to work with you!

A c c e l e r a t o r M a s s S p e c t r o m e t r y

Research Services for Drug Development